Elli Peselev

Array ( [id] => 5808331 [patent_doc_number] => 20060094686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Use of corrinoids for application in skin diseases' [patent_app_type] => utility [patent_app_number] => 11/303596 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2060 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094686.pdf [firstpage_image] =>[orig_patent_app_number] => 11303596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 377101 [patent_doc_number] => 07312201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-25 [patent_title] => 'Tetracyclic bicyclolides' [patent_app_type] => utility [patent_app_number] => 11/302525 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16130 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/312/07312201.pdf [firstpage_image] =>[orig_patent_app_number] => 11302525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632261 [patent_doc_number] => 20060148731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => '11,12-Lactone bicyclolides' [patent_app_type] => utility [patent_app_number] => 11/302529 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16464 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148731.pdf [firstpage_image] =>[orig_patent_app_number] => 11302529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4833909 [patent_doc_number] => 20080132456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Pharmaceutical Formulation Comprising Low Crystallinity Cellulose' [patent_app_type] => utility [patent_app_number] => 11/792217 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5035 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132456.pdf [firstpage_image] =>[orig_patent_app_number] => 11792217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6594191 [patent_doc_number] => 20100048498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'STABLE NON-DIHYDRATE AZITHROMYCIN ORAL SUSPENSIONS' [patent_app_type] => utility [patent_app_number] => 11/722279 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8028 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048498.pdf [firstpage_image] =>[orig_patent_app_number] => 11722279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806727 [patent_doc_number] => 07419962 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => '3,6-bicyclolides' [patent_app_type] => utility [patent_app_number] => 11/295736 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79484 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/419/07419962.pdf [firstpage_image] =>[orig_patent_app_number] => 11295736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4753174 [patent_doc_number] => 20080161249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Use of Novel Antibacterial Compounds' [patent_app_type] => utility [patent_app_number] => 11/718400 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12721 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20080161249.pdf [firstpage_image] =>[orig_patent_app_number] => 11718400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4772615 [patent_doc_number] => 20080058274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Combination Therapy' [patent_app_type] => utility [patent_app_number] => 11/667671 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13133 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058274.pdf [firstpage_image] =>[orig_patent_app_number] => 11667671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5331283 [patent_doc_number] => 20090111760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'MACROLONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/718529 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25635 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20090111760.pdf [firstpage_image] =>[orig_patent_app_number] => 11718529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746171 [patent_doc_number] => 20080090773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Macrolones - Amino Substituted Quinolones' [patent_app_type] => utility [patent_app_number] => 11/719004 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42714 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090773.pdf [firstpage_image] =>[orig_patent_app_number] => 11719004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916228 [patent_doc_number] => 20080096829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Macrolone Compounds' [patent_app_type] => utility [patent_app_number] => 11/718732 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31263 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096829.pdf [firstpage_image] =>[orig_patent_app_number] => 11718732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324228 [patent_doc_number] => 20090062218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'MACROLONE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/718532 [patent_app_country] => US [patent_app_date] => 2005-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47028 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062218.pdf [firstpage_image] =>[orig_patent_app_number] => 11718532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748628 [patent_doc_number] => 20060111560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Process for the preparation of crystalline form II of clarithromycin' [patent_app_type] => utility [patent_app_number] => 11/264835 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1642 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111560.pdf [firstpage_image] =>[orig_patent_app_number] => 11264835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614409 [patent_doc_number] => 20060116337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Use of glycyrrhizin and its derivatives as MCP-1 production inhibitors' [patent_app_type] => utility [patent_app_number] => 11/265328 [patent_app_country] => US [patent_app_date] => 2005-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4061 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116337.pdf [firstpage_image] =>[orig_patent_app_number] => 11265328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5808313 [patent_doc_number] => 20060094668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Coadministration of tigecycline and digoxin' [patent_app_type] => utility [patent_app_number] => 11/261259 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7245 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094668.pdf [firstpage_image] =>[orig_patent_app_number] => 11261259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436203 [patent_doc_number] => 20090170790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'KETOLIDE DERIVATIVES AS ANTIBACTERIAL AGENTS' [patent_app_type] => utility [patent_app_number] => 11/577900 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18073 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170790.pdf [firstpage_image] =>[orig_patent_app_number] => 11577900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5866034 [patent_doc_number] => 20060100165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Topical application of ivermectin for the treatment of dermatological conditions/afflictions' [patent_app_type] => utility [patent_app_number] => 11/255910 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4277 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20060100165.pdf [firstpage_image] =>[orig_patent_app_number] => 11255910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632260 [patent_doc_number] => 20060148730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Method of treating tuberculosis' [patent_app_type] => utility [patent_app_number] => 11/255380 [patent_app_country] => US [patent_app_date] => 2005-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8525 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148730.pdf [firstpage_image] =>[orig_patent_app_number] => 11255380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5721257 [patent_doc_number] => 20060074032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Synthesis and separation of optically active isomers of erythromycin and their biological actions' [patent_app_type] => utility [patent_app_number] => 11/254010 [patent_app_country] => US [patent_app_date] => 2005-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9267 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20060074032.pdf [firstpage_image] =>[orig_patent_app_number] => 11254010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5596838 [patent_doc_number] => 20060160756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Treatment and prevention of multi-drug resistance' [patent_app_type] => utility [patent_app_number] => 11/252245 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3710 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20060160756.pdf [firstpage_image] =>[orig_patent_app_number] => 11252245 [rel_patent_id] =>[rel_patent_doc_number] =>)